These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1389 related articles for article (PubMed ID: 20439427)

  • 1. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.
    Zhao B; Li L; Lei Q; Guan KL
    Genes Dev; 2010 May; 24(9):862-74. PubMed ID: 20439427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
    Zhao B; Lei QY; Guan KL
    Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.
    Chen L; Loh PG; Song H
    Protein Cell; 2010 Dec; 1(12):1073-83. PubMed ID: 21213102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for Hipk in the Hippo pathway.
    Heidary Arash E; Attisano L
    Sci Signal; 2013 May; 6(275):pe18. PubMed ID: 23674821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
    Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
    Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease implications of the Hippo/YAP pathway.
    Plouffe SW; Hong AW; Guan KL
    Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation and function of YAP transcription co-activator.
    Zhu C; Li L; Zhao B
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
    Kim NG; Koh E; Chen X; Gumbiner BM
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11930-5. PubMed ID: 21730131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snapshots of a hybrid transcription factor in the Hippo pathway.
    Luo X
    Protein Cell; 2010 Sep; 1(9):811-9. PubMed ID: 21203923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
    Miesfeld JB; Link BA
    Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing transcriptional and post-transcriptional roles for Scalloped in binary Hippo-dependent neural fate decisions.
    Xie B; Morton DB; Cook TA
    Dev Biol; 2019 Nov; 455(1):51-59. PubMed ID: 31265830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brahma regulates the Hippo pathway activity through forming complex with Yki-Sd and regulating the transcription of Crumbs.
    Zhu Y; Li D; Wang Y; Pei C; Liu S; Zhang L; Yuan Z; Zhang P
    Cell Signal; 2015 Mar; 27(3):606-13. PubMed ID: 25496831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
    Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA
    Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of a universal size-control mechanism in Drosophila and mammals.
    Dong J; Feldmann G; Huang J; Wu S; Zhang N; Comerford SA; Gayyed MF; Anders RA; Maitra A; Pan D
    Cell; 2007 Sep; 130(6):1120-33. PubMed ID: 17889654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mask is required for the activity of the Hippo pathway effector Yki/YAP.
    Sansores-Garcia L; Atkins M; Moya IM; Shahmoradgoli M; Tao C; Mills GB; Halder G
    Curr Biol; 2013 Feb; 23(3):229-35. PubMed ID: 23333314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation.
    Yu FX; Zhang Y; Park HW; Jewell JL; Chen Q; Deng Y; Pan D; Taylor SS; Lai ZC; Guan KL
    Genes Dev; 2013 Jun; 27(11):1223-32. PubMed ID: 23752589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus.
    Cho YS; Li S; Wang X; Zhu J; Zhuo S; Han Y; Yue T; Yang Y; Jiang J
    Genes Dev; 2020 Jan; 34(1-2):53-71. PubMed ID: 31857346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.